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ABSTRACT Yeast cytosine deaminase, a zincmetalloenzyme, catalyzes the deamination of cytosine to uracil. Experimental and
computational evidence indicates that the rate-limiting step is product release, instead of the chemical reaction step. In thiswork, we
usemolecular dynamics to suggest ligandexit paths.Simulationat 300Kshows that theactive site iswell protectedby theC-terminal
helix (residues150–158) andF-114 loop (residues111–117) and that on themolecular dynamics timescalewater doesnot ﬂow in or
out of the active site. In contrast, simulation at 320 K shows a signiﬁcant increase in ﬂexibility of the C-terminal helix and F-114 loop.
The motions of these two regions at 320 K open the active site and permit water molecules to diffuse into and out of the active site
through two paths with onemuch more favored than the other. Cytosine is pushed out of the active site by a restraint method in two
directions speciﬁed by these two paths. In path 1 the required motion of the protein is local—involving only the C-terminal helix and
F-114 loop—and two residues, F-114 and I-156, are identiﬁed that have to bemoved away to let cytosine out; whereas in path 2, the
protein has to rearrange itself much more extensively, and the changes are also much larger compared to the path 1 simulation.
INTRODUCTION
Yeast cytosine deaminase (yCD) catalyzes the deamination of
cytosine to uracil. Cytosine deaminase is present in bacteria
and fungi as part of the pyrimidine salvage pathway but is
absent in mammals (1). yCD can also catalyze the deamina-
tion of the prodrug 5-ﬂuorocytosine (5-FC) to the anticancer
drug 5-ﬂuorouracil (5-FU). Thus, a potential system for gene-
directed enzyme prodrug therapy combines yCD and the
prodrug 5-FC, since the product, 5-FU, inhibits DNA syn-
thesis and is thus a potent chemotherapeutic agent (2).
X-ray structures of yCD in the apo form (3) and in complex
with the potent inhibitor 2-pyrimidinone (3,4) are available.
yCD is a homodimerwith one active site in each protomer. The
yCD protomer contains a center b sheet (b1;b5, parallel to
each other) with two a helixes (a1 and a5) on one side and
four a helixes (a2, a3, a4, and a6) on the other side. Each
active center contains a single catalytic zinc ion that is
tetrahedrally coordinated with a histidine (H-62), two cyste-
ines (C-91 and C-94), and a water molecule in the substrate-
free enzyme or the inhibitor in the complex. Surprisingly, the
structure of apo yCD is essentially the same as that of the
transition state analog complex with the active site completely
buried. Previous molecular dynamics (MD) simulations for
the apo form and reactant various intermediate and product
complexes (5) all showed a buried active site during the
;2.0-ns simulations. The protein overall is quite rigid in those
simulations, consistent with NMR backbone nuclear Over-
hauser effect data and order parameters (L. Yao and H. Yan,
unpublished data), which describe motion in the picosecond-
nanosecond timescale. Quench-ﬂow experiments performed
to study the reaction mechanism indicate that product release
is the rate-limiting step during the activation of 5-FC (6). A
slow product release process was also demonstrated by a
19F-NMR study, with the product release rate determined to
be ;13 s1 (6). To enhance the product release rate, and
therefore improve the efﬁciency of this enzyme, which is the
essential goal of our study, the product release process has to
be understood.
The slow product release is most likely due to subtle
conformational transitions in the protein. To identify potential
ligand release paths, we have performedMD simulations with
the use of a restraint method that is derived from umbrella
sampling methods. The aim of this study is to explore the
dynamic process of product release rather than constructing a
potential of mean force (PMF) since, ﬁrst, the product release
path is unknown and, second, the product release rate is in the
seconds timescale, which is much longer than an MD sim-
ulation can reach. Even the use of umbrella sampling-based
methods (7) in this case where there must be large barriers
to product release would make the calculation of a PMF
extremely difﬁcult. It would also be less meaningful for our
purposes. Instead, we believe that identifying the product
release path is more important and can guide experimental
mutagenesis studies, which in turn could conﬁrm our com-
putational work. For these reasons we adopt a methodology
that is quite similar to steered molecular dynamics (SMD),
which has been used extensively in studying protein ligand
binding and unbinding process in various systems (8,9). The
only difference is that in steered MD the ligand is usually
pushed continuously, whereas in our case the ligand is pushed
out to be centered around a series of distances for a given
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number ofMD steps, and then the rest of the system is allowed
to relax to the given distance restraint.
But, before pushing the ligand out of the active site, potential
paths must be chosen. The small root mean square deviation
(RMSD) between the apo and transition state analog complex
x-ray structures, including the residues that surround the active
site, suggests that for yCD typical nanosecond simulations at
300 K can hardly give us valid information about the ligand
release path and the residues that are involved in the release. So,
the strategy we adopt is to perform one regular simulation for
the apo enzyme at 300 K and another at 320 K. By comparing
these two trajectories, we might be able to identify the ‘‘soft
spot’’ of the protein. The higher temperature provides larger
thermal ﬂuctuations and therefore a better chance for the
protein to overcome certain barriers to reach some conforma-
tions that are less populated at 300 K. In this case, these
conformations would correspond to the opening of the active
site while still maintaining the protein’s secondary and tertiary
structure. The simulation results show that the ﬂexibility of
certain residues does increase signiﬁcantlymore thanothers. In
particular, the F-114 loop (residues 111–117) and C-terminal
helix (residues 150–158) that cover the active site do ﬂuctuate
more when comparing the 300-K and 320-K simulations. The
motions of these two regions at 320 K open the active site and
permit water molecules to diffuse into and out of the active site
through two paths. Based on the identiﬁcation of these paths,
cytosine was pushed out of the active site and the residues that
respond to the release monitored. In this manner, motions of
yCD regions required to release the ligand could be suggested.
METHODS
MD simulation of the yCD apo form
The parameterization of the force ﬁeld for Zn complexeswas described in detail
in a previous article (5). The protonation states of the ionizable residueswere set
to their normal ionization states at pH 7. The protein was surrounded by a
periodic box of approximate dimensions 903 883 70 A˚ leading to solvation
by ;17,000 TIP3P water molecules. Six Na1 ions were placed by the LEAP
program (10) to neutralize the 6 charges of the model system. The parm94
version of the all-atom AMBER force ﬁeld was used to model this system.
MD simulations were carried out using the SANDER module in AMBER
7.0 (11) at constant pressure and temperature. The time step was 2 fs, and the
SHAKE algorithmwas used to constrain all bonds involving hydrogen atoms.
A nonbond pair list cutoff of 8.0 A˚ was used and the pair list updated every 25
steps. The pressure and the temperature (300 K and 320 K) of the systemwere
controlled during theMDsimulations byBerendsen’smethod (12). To include
the contributions of long-range electrostatic interactions, the particle mesh
Ewaldmethod was used (13). A 2-ns simulationwas performed at 300 K, with
500psof equilibration time.The 320-Ksimulation protocol is slightly different
from the 300Kone.After a 1-ns simulation, 3 ns of simulationwere continued.
Meanwhile, four other 1-ns independent simulations were started by reassign-
ing the atom velocities to the last snapshot of the ﬁrst nanosecond simulation
based on theMaxwell-Boltzmann distribution at 320K. So effectively, an 8-ns
simulationwas done at 320K. The ﬁrst 500 ps of the regular simulation and the
ﬁrst 200 ps of the velocity-reassigned simulations were treated as equilibration
periods and therefore not included in the data analysis.
The coordinates were saved every 2 ps and were analyzed with the Moil-
View program and the PTRAJ module of AMBER 7.0. Principal component
analysis (PCA) was performed by using the gcovar and ganaeig modules in
GROMACS to ﬁlter out the fast motions (14).
Pushing ligand out of the active site
A 2-ns MD simulation was previously performed for the yCD uracil (product)
complex at constant temperature (300 K) and volume (5). The simulation
showed that the active sites in both protomers are buried and the protein overall
is quite rigid, similar to the 300-K 2-ns simulation of the apo form. But, the O4
of uracil is covalently linked to the Zn atom of the active site, which raises a
difﬁculty for the product release path study. On the other hand, the reactant
cytosine has a very similar structure to the product uracil and similar active site
interactions. Furthermore, the yCD cytosine complex 300-K MD simulation
also shows that the protein is rigid and that the active site remains buried (5).
Thus, cytosine is used as the ligand to be pushed out of the active site.
To explore how cytosine gets out of the active site, a restraint was
introduced to push it along the two paths that we identiﬁed by examining the
data from the 320-Kapo form simulation. The ﬁrst path is in between the F-114
loop (residues 111–117) and the C-terminal helix (residues 150–158), and the
second path is in between loop 1 (residues 53–61) and the C-terminal helix. A
harmonic potential was added between the center of mass (COM) of the cyto-
sine ring heavy atoms and the COM of backbone heavy atoms of H-50 (S-89)
in path 1 (2). The reasons to choose H-50 are that it is from the core region (b2)
and therefore quite rigid, and it is along the path 1 direction of ligand release.
Similar reasoning was used in choosing S-89 in path 2. The starting structure
was taken from one snapshot of the cytosine complex MD simulation. The
equilibriumdistancewas increased0.1 A˚ once every 120ps to give an effective
force to push cytosine out of the active site. The 120-ps simulation in between
two neighboring pushes allows the system to relax and permits a better
statistical evaluation of the force needed to push the ligand out. Cytosineswere
pushed 13 A˚ along path 1 in protomer 1 and path 2 in protomer 2 in a total of
15.6 ns of simulation time, giving the effective pushing rate of;0.82 A˚/ns.
The pushing velocity is an important parameter in the simulation.
Considering that the experimental rate of product release is 13 s1, which is
impossible to simulate with current computer resources, we use a pushing
speed as slow as is practical tomimic the unbinding process. The speedwe use
is considerably slower than the rate typically used (15–17). As noticed in an
unbinding study of an acetylcholinesterase ligand complex (16), the slower
the pushing rate, the smaller the irreversible work needed to push the ligand
out. The slower pushing rate would allow the ligand to explore more
conﬁguration space and be more likely to ﬁnd the real path(s). On the other
hand, our test simulations with a faster pushing velocity (7 A˚/ns), starting
from different initial structures, showed no sign of distortion of the overall
structure of the protein. Thus, the velocity we adopted (0.82 A˚/ns) is a
reasonable compromise between computational cost-based considerations
and the genuine property of the system. As discussed above, the aim of this
study is to discover potential ligand release paths and consequent protein
dynamics rather than an evaluation of the PMF for ligand release.
The force constant used is 20 kcal/(mol-A˚2), which corresponds to a
thermal ﬂuctuation of distance of ;0.25 A˚. This pushing rate provides a
continuous sampling of the cytosine release path. Test simulations with the
7-A˚/ns pushing speed showed that this force constant is large enough to push
cytosine out efﬁciently—similar to the pushing simulations performed on
another system we studied (18) and consistent with what other researchers
used in ligand-unbinding studies (8,15,19). The restraint force was calculated
and averaged over each window. The ﬁrst 20 ps of simulation in a given
window was treated as the equilibration period and therefore not included in
the force calculation.But, in theRMSDcalculation between the instantaneous
MD trajectory and the crystal structure, all the snapshots were used since no
apparent difference can be seen between the equilibration and data collection
period in terms of structure.
Since the two ligands were pushed out simultaneously along two
different paths, it might cause some synchronized artiﬁcial effect. To make
sure this is not the case, a simulation where a single ligand was pushed along
path 1 (at the rate of 7 A˚/ns) was carried out. No changes in the dynamics of
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the active site in the adjacent protomer were found, probably because the two
active sites are;18 A˚ apart, and the pushing simulation results in the ligand
farther away from the adjacent active site.
RESULTS AND DISCUSSION
Apo form simulations at 300 K and 320 K
yCD is a homodimer with 158 residues in each subunit. The
data analysis was based on each subunit to improve the
statistics because the crystal structure shows that the two
subunits are the same, except for several N-terminal residues.
Because previousMDsimulations showed that theN-terminus
is farmore ﬂexible than the rest of the protein (5) and is also far
away from the protein active site, the ﬁrst 14 residues were not
included in the ﬁtting for the calculation of theRMSDfrom the
crystal structure or the root mean-square ﬂuctuation (RMSF)
from the average structure.
The time evolutions of the a-carbon (CA)-based RMSD of
MD snapshots from the crystal structure stabilize after 500 ps,
indicating that the two systems are in equilibrium during the
analyzed trajectory (data not shown). Fig. 1 showsRMSFplots
at 300 and 320 K for the two different subunits, as well as the
RMSF calculated from the crystal B-factors. As can be seen,
they are consistent with the crystal B-factors. The protein
overall is quite rigid with average RMSF;0.41 A˚ and;0.44
A˚ for protomer 1 and 2, respectively, at 300K. The increase of
temperature from 300 K to 320 K causes a signiﬁcant increase
of protein ﬂexibility (Fig. 1). The averageRMSFs are;0.62 A˚
for protomer 1 and;0.67 A˚ for protomer 2 at 320 K, ;50%
larger than those at 300 K. This ﬂexibility increase mainly
comes from the relatively ﬂexible regions at 300 K, among
which the C-terminal helix shows the largest RMSF increase
in both protomers (Fig. 1). Since the C-terminal helix covers
the active site, as shown in the crystal structure (3,4), the sig-
niﬁcant increase of RMSF in this region might be important to
open up the active site and let the reactant enter and exit it.
To exploremore details about the protein ﬂuctuation changes
due to the increase of temperature, a PCA (20,21) was used to
analyze the MD trajectories. PCA attempts to decompose the
overall atom ﬂuctuations into a small set of modes that encom-
pass a large percentage of the overall RMSF2 and amuch larger
set of modes that contribute a relatively small amount. In this
way,we can focus on the small set ofmodes that represent slow,
large-scale motions because large portions of the ﬂexibility
change usually come from these modes. By comparing these
signiﬁcantmotionmodes at the two temperatures,we canobtain
instructive information about large-scale motions that might be
responsible for ligand binding or release.
As shown in Table 1, the total variance (RMSF2) of the CA
atoms (residues 15–158) is;25 A˚2 and;29 A˚2 for protomer
1 and 2, respectively, at 300 K. The 320-K simulation gives
much bigger variances with;65 A˚2 for protomer 1 and;76
A˚2 for protomer 2. It is surprising that the total ﬂuctuations
approximately double even though the temperature only
increases ;7%. Assuming harmonic vibrational motion for
the CA atoms, the increase of total variance should scale with
the temperature increase. The large deviation from this expec-
tation might be due to two main reasons. First, the increase of
temperature gives a better chance to overcome certain barriers
and therefore explore conﬁguration space more effectively.
Second, the longer simulation time at 320 K (8 ns) can also
cover more conﬁguration space than the 2-ns simulation at
FIGURE 1 CA RMSFs of protomer 1 (a) and protomer 2 (b) at 300 K
(solid line) and 320 K (dotted line). The crystal B-factors were converted
(23) to RMSFs (dashed line). The heavy black lines show the RMSF
differences between the 300 K and 320 K data.
TABLE 1 Total CA ﬂuctuations (RMSF2) and percentage
contributions from the ﬁrst ﬁve PCA modes at 300 K
and 320 K
300 K 320 K
Protomer 1 Protomer 2 Protomer 1 Protomer 2
CA ﬂuctuation (A˚2) 25.4 29.4 65.1 76.1
First ﬁve modes 24% 29% 48% 47%
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300 K. Nevertheless, it is signiﬁcant that a small increase of
temperature triggers such a dramatic ﬂuctuation change
without denaturing the protein and indicates that new, slower
functional motion modes might be captured in the 320-K
simulation.
To see whether these suppositions are true, the PCA was
used to ﬁlter out the fast motions and keep the slow ones of
primary interest. The ﬁrst ﬁvemodes contribute 24% and 29%
at 300 K compared with 48% and 47% at 320 K to the total
RMSF2 for protomers 1 and 2, respectively. The ﬂuctuation
difference in the ﬁrst ﬁve modes between these two temper-
atures is ;25 A˚2 (;27 A˚2) for protomer 1 (2), contributing
63% (73%) of the total ﬂuctuation difference. Thus the major
motion differences between the 300 K and 320 K simulations
were captured in the ﬁrst ﬁve modes.
The RMSF plots of individual residues at these two
temperatures can provide information about which regions
have large ﬂexibility changes. Fig. 2 shows the CA RMSFs
corresponding to the ﬁrst ﬁve modes. The main difference
between the 300 K and 320 K results is from the ﬂexible
regions. Though the trajectories of these two protomers show
some differences of the ﬂexibility increase in certain regions,
such as residues 120–125 (part of helix 4) and 144–149 (part
of helix 5), which is probably due to incomplete sampling of
conformation space, both protomers show consistently large
RMSF differences in the C-terminal helix and F-114 loop
regions. To get a better view of the ﬂexibility changes, a
schematic graph was generated by superimposing the 50 MD
CA snapshots projected onto the ﬁrst ﬁve modes for indi-
vidual protomers at these two simulation temperatures (Fig.
3). Clearly, the C-terminal helix and F-114 loop show much
larger ﬂuctuations at 320 K than those at 300 K. Furthermore,
it reveals that the motion of these two regions can expose the
active site to the solvent, whereby water molecules can move
freely in and out of the active site, unlike the 300-K simulation
in which the active site is completely buried (Fig. 3). We
identiﬁed a total of 27 water molecules that diffuse into the
active site and 11 water molecules that diffuse out through the
path in between the C-terminal helix and F-114 loop in both
protomers (Fig. 4). The 300-K MD simulation shows that the
side chains of F-114, W-152, and I-156 cover the active site,
whereas F-114 and I-156 block this path. The increase of
ﬂexibility of the C-terminal helix and F-114 loop at 320 K
moves these two side chains slightly away from their original
positions; as a consequence the active site is opened up. Three
residues, C-91, F-114, and I-156, were used to deﬁne qual-
itatively the entrance of this water path (Fig. 4). Labeling the
C-91 CA-F-114 CZ distance as d1, the C-91 CA-I-156 CD
distance as d2, and the F-114 CZ-I-156 CD distance as d3 and
parametrically plotting these distances for the 300-K and 320-
K simulations in three-dimensions (3D) reveals that at 300 K
the distances are restrained in the lower left corner, whereas at
320 K they are spread from the lower left toward the upper
right in the orientation of the ﬁgure. The average distances and
their ﬂuctuations for d1, d2, and d3 are 5.256 0.72 A˚, 8.046
1.04 A˚, and 4.65 6 0.64 A˚ at 300 K compared with 7.73 6
1.90 A˚, 10.20 6 1.28 A˚, and 6.12 6 1.20 A˚ at 320 K in
protomer 1. All the distances and their ﬂuctuations are
increased at 320 K, indicating that the mouth of the active site
has opened up and the breathing motion is larger at this
temperature. The 320 K data, projected onto the three two-
dimensional (2D) planes formed from these distances in Fig. 5
b, show that the two-state behavior evident in Fig. 5 amainly
arises from the C-91CA-F-114CZ distance coordinate. Thus,
there are barriers that are overcome during the simulation at
the higher temperature.
It is interesting that one water molecule moves out of the
active site in protomer 2 through the path in between the
C-terminal helix and the loop between a2 and b2 (residues
51–61), which we refer to as loop 1 (Fig. 4). As shown in Fig.
2, loop 1 is also relatively more ﬂexible at 320 K. Thus, two
water diffusion paths were identiﬁed. But, it seems that the
path in between the F-114 loop and C-terminal helix (path 1)
is much more favorable than the path in between the
FIGURE 2 CA RMSF plots corresponding to the ﬁrst ﬁve PCA modes at
300 K and 320 K and their difference: (a) protomer 1, and (b) protomer 2.
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C-terminal helix and loop 1 (path 2), particularly considering
that the natural reactant cytosine and the product uracil are
much larger than a water molecule. There are 28 events
observed for water passing through path 1 but only one event
for water passing through path 2. Further investigations of
these two pathswere carried out by pushing cytosine out of the
active site along these two paths as described below.
To summarize the apo simulation results, the 320-K MD
simulation increases the ﬂexibility of the protein, and most of
the increase comes from some large-scale (slow) motionmodes
that have relatively large barriers to overcome. The use of high
temperature and a longer simulation time provides a greater
chance to overcome these barriers and obtain a better descrip-
tion of the protein dynamics. Two pathways were identiﬁed for
waterdiffusion into andoutof the active site,whichare potential
paths for ligandbindingor releasedue to the increasedmotionof
loop 1, the F-114 loop, and the C-terminal helix.
Pushing cytosine out of the active site
To determinewhether the twowater paths identiﬁed in the apo
protein simulation are sensible paths for product release, the
reactant cytosine was pushed 13 A˚ away from the active site
through these two paths in a 15.6-nsMD simulation.We chose
to push cytosine out of the active site because in theMichaelis
complex cytosine is not coordinated with the Zn (22). Along
the pushing paths, the structure and ﬂexibility changes for the
overall protein and individual regions can be investigated and
the cytosine-protein restraint force calculated to understand
better these two paths and their inﬂuence on the overall protein
and its various regions. Several residues were identiﬁed that
may potentially contribute to the slow product release process.
Path 1
In path 1, a harmonic restraint was added between the COM
of the cytosine heavy atoms and the COM of the backbone
heavy atoms of H-50. This residue is from the b2 region,
which is quite rigid and aligned along the path. So, this
residue was selected as the anchor to implement the restraint
force, with the parameters given in Section II.
Fig. 6 a shows the RMSD (relative to the cytosine yCD
complex crystal structure) of all the CAs versus time, with
zero time corresponding to a snapshot from a normal MD
simulation of the complex. Over the ﬁrst 7 ns the RMSD is
stable at ;0.9 A˚, which is comparable to the normal MD
complex simulation, and then increases slightly to ;1.1 A˚.
The whole protein is quite rigid and the perturbation of the
FIGURE 3 Schematic graph of 50 trajectory snapshots
of CA atoms projected out of the ﬁrst ﬁve PCA motion
modes at 300 K and 320 K. The F-114 loop and C-terminal
helix were labeled to give a better view. Water molecules
can diffuse into the active site at 320 K through the path in
between F-114 loop and C-terminal helix but not at 300 K.
FIGURE 4 One snapshot of the apo MD simulation at 320 K. Water
molecules diffuse into the active site through the triangle mouth deﬁned by
C-91, F-114, and I-156.
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overall structure is rather small during the ligand release. Fig.
6 b shows the average pushing force in each window. From
the RMSD plot and the force plot (Fig. 6, a and b) it appears
that there are two periods for the reactant exit; a ﬁrst period
from the beginning to around the seventh nanosecond and a
second period from the seventh nanosecond to the end. In the
ﬁrst period, the overall structure changes are quite small. The
main barrier comes from the direct hydrogen-bonding inter-
actions lost between cytosine and the residues in the active
site, which can be conﬁrmed by a hydrogen-bond analysis.
Fig. 6 c shows the lifetime of the hydrogen bonds during the
pushing simulation. There are ﬁve hydrogen bonds between
cytosine and the protein, including N-51, G-63, E-64, and
D-155, when cytosine is well bound in the active site. All these
hydrogen bonds are eventually lost during the ﬁrst period of
the pushing simulation. The hydrogen bond with G-63 breaks
ﬁrst, at;3 ns, primarily because G-63 sits at the bottom of the
active site and the hydrogen-bond donor, the backbone amide,
is quite rigid. Then E-64 and N-51 lose their three hydrogen-
bond interactions with cytosine at;5 ns. Lastly, the hydrogen
bond between D-155 and cytosine is broken at;7 ns. During
FIGURE 5 (a) 3D plots of distances d1 (C-91 CA-F-114 CZ), d2 (C-91
CA-I-156 CD), and d3 (F-114 CZ-I-156) at 300 K (black) and 320 K (gray).
(b) The 320-K data plot (black) with the three 2D projections (gray).
FIGURE 6 (a) TotalCARMSDversus timeobtainedby comparing theMD
snapshots with the apo yCD crystal structure. (b) The window-averaged
restraint force between cytosine and the protein in eachwindow. (c)Hydrogen-
bond lifetimes between cytosine and the protein during the cytosine pushing.
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the second period, since all the original hydrogen bonds with
cytosine have broken, the force needed to push the ligand out
probably mainly comes from steric hindrance and conforma-
tional rearrangements of the residues along the path.
To understand how the cytosine-pushing procedure affects
the dynamics of individual regions or residues, CA RMSFs
are plotted in Fig. 7. Fig. 7 a shows the CA RMSFs of the
regular MD simulation. They are quite similar to those of the
regular simulation of the apo enzyme at 300K. Fig. 7, b and c,
indicates that, during the pushing of cytosine, the protein
overall becomes more ﬂexible and the RMSF increases when
the ﬁrst and second stages of the pushing are compared with
the regular simulation. The total ﬂuctuations of the CA atoms
are 35.8 A˚2, 50.6 A˚2, and 59.3 A˚2 for the regular, stage 1, and
stage 2 simulations, respectively. Since the active site remains
buried during the regular simulation, the protein has to move
certain regions or residues to open up the active site to let
cytosine out, which causes the observed increase in ﬂuctu-
ation. Fig. 7, b and c, shows that these RMSF increases are
mainly concentrated in the C-terminal helix and F-114 loop,
which is consistent with the results of the 320 K apo form
simulation (Fig. 1). The increases in the RMSFs of these two
regions suggest that motions of these two parts are important
for ligand release. Therefore, the motion of the protein
required for ligand release is local, and the structural per-
turbation is small. It appears that the motion of the C-terminal
helix is larger in stage 2 than that in stage 1. TheMD trajectory
shows that at the end of stage 2 cytosine moves out of the
active site completely. The tip of the C-terminus moves close
to the active site, partly to occupy the space vacated by
cytosine and, consequently, blocks the active site, which
effectively imparts to the C-terminal helix a relatively large
motion. The unbinding process of cytosine can be illustrated
by a schematic graph of the CA ﬂuctuations. In a manner
similar to the apo form simulation analysis, PCA was used to
ﬁlter out the high frequency motions and only the ﬁrst ﬁve
modes were used to construct the schematic plot that is
composed of the superposition of 50 MD snapshots. As
shown in Fig. 8 a, the whole protein is rather rigid, including
the F-114 loop and C-terminal helix in the regular 2-ns MD
simulation of the cytosine complex. Fig. 8 b shows the
increase of the ﬂuctuation in these two regions in the ﬁrst stage
of pushing, and Fig. 8 c describes a similar increase. Note that
some of the snapshots show that the C-terminal helix moves
closer to the active site in the second stage. A movie of the
trajectory reveals that, in stage 2, the C-terminal helix and
F-114 loop undergo a concerted ﬂapping motion, which
effectively opens up the active site and subsequently closes it
after the release of cytosine (see discussion below). Besides
the changes of these two regions, a small helix (residues;75–
80) also shows enhanced ﬂuctuations during the pushing
simulation (Fig. 7, b and c). Further inspection shows that this
region is in close contact with the C-terminal helix of the
adjacent protomer and suggests that this enhanced ﬂuctuation
of the small helix might be caused by the motion of that
FIGURE 7 (a) CA RMSFs in 2-ns regular MD simulation. (b) RMSF
difference obtained by comparing the ﬁrst stage of cytosine pushing with the
regular simulation. (c) RMSF difference obtained by comparing the second
stage with the regular simulation.
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C-terminal helix where cytosine was pushed out along path 2
simultaneously.
The MD trajectory shows that the cytosine release path is
slightly different from thewater diffusion path thatwas found in
the apo form simulation. Unlike water diffusing through the
triangle mouth deﬁned by C-91, F-114, and I-156, the cytosine
release path drifts slightly away to lie in between F-114 and
I-156 (Fig. 9). The mass-weighted RMSDs of F-114 and I-156
are plotted inFig. 10.TheRMSDofF-114changesdramatically
during the pushing simulation but eventually returns to be close
to its initial position. Comparedwith F-114, themotion of I-156
is smaller (Fig. 10) but has a similar pattern to the whole
C-terminal helix, and at the end it also goes back to ;1 A˚
RMSD, indicating that this residue returns to its original
conformation. Apparently, F-114 undergoes a large ﬂapping
motion during stage 2,which opens up the active site and assists
the release of cytosine, whereas the C-terminal helix moves
slightly away tomake the entrance larger. Then both come back
to cover the active site after the release of cytosine. It appears
that the C-terminal helix moves as a whole block, whereas
F-114moves in addition to the loopmovement, because there is
no secondary structure restraint in the loop region. As a result,
the motion scale of F-114 is much larger than that of I-156.
Path 2
Cytosine in protomer 1 was pushed out along path 2, which is
deﬁned as in between the C-terminal helix and loop 1 (Fig. 9).
According to the 320-K simulation of the apo enzyme, it seems
that this path is much less popular for water to diffuse through
than path 1. Fig. 11 a shows the RMSD along path 2 of all the
CA atoms based on superposition with the crystal structure. It
increases from;0.8 A˚ to;1.4 A˚, which is larger than that of
path 1,which increases from0.9 A˚ to 1.1 A˚, suggesting that the
overall protein has to move more when cytosine releases
through this path. This couldmake the release harder. The total
CA ﬂuctuation is 92.5 A˚2 (for protomer 2), much larger than
that in the regular simulation (25 A˚2 (29 A˚2) for protomer
1 (2)). The CA RMSF differences are presented in Fig. 11 c.
It appears that many regions in the protein have larger ﬂuc-
tuations, especially those ﬂexible regions identiﬁed in the
regular 320K apo form simulation (Fig. 1). Therefore, it seems
that the protein has to rearrange many regions in a concerted
mannerwhen cytosine releases through this path, in contrast to
FIGURE 8 Schematic graphs of 50
trajectory snapshots of CA atoms pro-
jected out of the ﬁrst ﬁve PCA motion
modes: (a)Regular simulation. (b) Push-
ing simulation stage 1. (c) Pushing
simulation stage 2.
FIGURE 9 The cytosine release paths found from the pushing simulation.
FIGURE 10 Mass-weighted RMSD plots of F-114 and I-156 along push-
ing path 1 of cytosine.
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path 1where only the F-114 loop andC-terminal helix regions
need to move away and the perturbation is rather local and
small. An analysis of the MD trajectory shows that along this
path cytosine ﬁrst pushes aside V-31, N-51, and D-155 and
breaks the hydrogen bonds with the latter two residues and
then moves away from D-151 (which is salt bridged with
R-148). After that, it rearranges the side chain of F-54 to gain
enough space to exit. It appears rather hard for a ligand tomove
through this path. The force used to push cytosine out is
presented in Fig. 11 b. The average force is;5.6 kcal/mol-A˚,
which is about two times larger than that in path 1 (;3.2 kcal/
mol-A˚), implying that more work has to be done in path 2. The
root mean-square force ﬂuctuation is also larger in path 2 (4.5
kcal/mol-A˚) than path 1 (2.8 kcal/mol-A˚), so the energy
surface may be rougher along path 2.
Thus, from the energetic and structural points of view,
path 2 is not favorable compared with path 1 in the current
simulations. To release the ligand along path 2, many regions
have to move, including the C-terminal helix and F-114 loop,
which are the only parts required to move signiﬁcantly when
cytosine is released along path 1. In fact, the F-114 loop has
the largest ﬂuctuation changes in the path 2 simulation
because cytosine pushes the C-terminal helix close to the
F-114 loop and therefore moves this loop away.
It appears that in both pathways the C-terminal helix is very
important, acting like a lid covering the active site. In both
unbinding simulations (paths 1 and 2) the C-terminal helix
moves as a whole block. The x-ray structure shows that this
helix is negatively charged (4, including D-151, E-154,
D-155, andE158), and there are four salt bridgeswith residues
from other regions, including D-151–R-148, E-154–R-53,
E-154–R-73* (from the adjacent protomer) and D-155–R-53,
which restrain this helix. During the pushing simulation, all
these salt bridges are well maintained.
CONCLUSIONS
In this study, we used MD to explore possible ligand release
paths from yCD. The 300-K apo enzyme simulation main-
tains a closed active site, consistent with the crystal structure.
Overall, the protein is quite rigid, a feature that has been
conﬁrmed by NMR backbone relaxation experimental data
(L. Yao and H. Yan, unpublished). Finding exit pathways for
ligands when a protein has a deep cleft leading to the active
site can often be inferred by examination of crystal structures.
For yCD, the active site is completely buried and the choice of
potential paths by simple inspection of a crystal structure
could be misleading. Here, the use of a higher temperature
simulation was essential for identifying potential exit paths.
The 8-ns 320-K simulation shows a strikingly large increase
of ﬂexibility in some regions of the protein while maintain-
ing the secondary and tertiary structure of the protein. The
increases of ﬂexibility in the C-terminal helix and F-114 loop
regions, which open up the closed active site, are most signiﬁ-
cant. Water molecules are found to diffuse into the active site
FIGURE 11 (a) RMSD of all CA atoms compared with the cytosine yCD
crystal structure. (b) The window-averaged restraint force calculated for
cytosine pushing along path 2. (c) The CA ﬂuctuation differences between
the regular and cytosine pushing simulations.
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through two paths. One path is in between the F-114 loop and
C-terminal helix, and the other is in between loop 1 and the
C-terminal helix. The former path appears to be much more
popular, with themouth of the entrance deﬁned by a triangular
area formed by the residues C-91, F-114, and I-156. This area
and its ﬂuctuations are much larger at 320 K than at 300 K
(Fig. 5), which allows water molecules to frequently move in
and out of the active site.
Cytosine was pushed out of the active site along these two
paths by 13 A˚ in a 15.6-ns simulation. The results show that in
path 1 the required motion of the protein is quite local, only
involving the C-terminal helix and F-114 loop. Two residues,
F-114 and I-156, are identiﬁed that have to be moved away to
let cytosine out; whereas in path 2, the protein has to rearrange
itself quite globally, and the changes are also much larger
compared to the path 1 simulation. The average force along
the path and its ﬂuctuation are larger in path 2 than in path 1,
suggesting that the barrier is higher and the energy surface
along the release path is rougher in path 2. Several residues
have to be moved away including V-31, N-51, and D-155
ﬁrst, and then D-151, and ﬁnally F-54. This path is usedmuch
less frequently for water molecules relative to path 1, andmay
be difﬁcult for cytosine exit because of its larger size in
comparison with water. However, path 2 cannot be excluded
on the basis of the simulations alone, in view of the limited
timescale available to MD simulations.
The simulations show that, for both paths, the C-terminal
helix is critical for ligand release. Note that the C-terminal
helix is well restrained by four salt bridges and several
hydrogen bonds with residues in other regions. Byweakening
these salt bridge interactions, the ﬂexibility of the C-terminal
helixmight be increased, and that couldmake cytosine release
faster. Or, on the other hand, by mutating F-114 or I-156
(residues along the path) to smaller residues, ligand release
also could be assisted. As discussed above, opening the active
site limits the ligand escape process. From the experimental
point of view, the protein modiﬁcations described above
might be able to improve the product release rate and thereby
enhance the protein’s activity. To this end, experimental
mutagenesis studies are under way. It will be interesting to see
whether they will conﬁrm our computational study.
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